COVID-19 Critical Care Consortium Observational Study Incorporating the Extracorporeal Membrane Oxygenation for 2019 Novel Coronavirus Acute Respiratory Disease (ECMOCARD)

COVID-19 can cause severe respiratory illness requiring intensive care support. This international observational registry study tracks patients with confirmed or suspected COVID-19 who are admitted to intensive care units, with a particular focus on those who require mechanical ventilation or ECMO (extracorporeal membrane oxygenation — a life support machine that does the work of the lungs). The study also examines blood clotting problems, which are common in severe COVID-19. There is no experimental treatment in this study. Instead, clinical teams at participating ICUs around the world record detailed information about their COVID-19 patients' illness course, treatments used, complications, and survival outcomes. This data helps build a global picture of how the disease affects critically ill patients and how different treatment strategies compare. You may be eligible if you are admitted to an intensive care unit at a participating centre with confirmed or clinically suspected COVID-19 infection. The study does not have specific age restrictions. Patients on mechanical ventilation or ECMO for reasons unrelated to COVID-19 are not eligible.